Xiidra (Shire US Manufacturing Inc.)


Welcome to the PulseAid listing for the Xiidra drug offered from Shire US Manufacturing Inc.. This Lymphocyte Function-Associated Antigen-1 Antagonist [EPC],Lymphocyte Function-Associated Antigen-1 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Shire US Manufacturing Inc.
NON-PROPRIETARY NAME: Lifitegrast
SUBSTANCE NAME: LIFITEGRAST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lymphocyte Function-Associated Antigen-1 Antagonist [EPC],Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-07-11
END MARKETING DATE: 0000-00-00


Xiidra HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXiidra from Shire US Manufacturing Inc.
LABELER NAME: Shire US Manufacturing Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2016-07-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54092-606_b9283437-01b2-4246-bf7a-054bfb3efa1c
PRODUCT NDC: 54092-606
APPLICATION NUMBER: NDA208073

Other LIFITEGRAST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Shire US Manufacturing Inc.Xiidra